Mabpharm Limited (02181.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−279.4x

Market Cap

HKD 1.83B

MomentumView details →

1D Return

+0.00%

YTD Return

−11.00%

RSI (14)

61.8

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−279.4x

Market Cap

HKD 1.83B

RSI (14)

61.8

MomentumView details →

1D Return

+0.00%

YTD Return

−11.00%

ProfitabilityView details →

Gross Margin

85.63%

Net Margin

−7.99%

EBITDA Margin

−0.71%

ROE (TTM)

−45.57%

ROA (TTM)

−6.22%

Asset Turnover

0.81x

GrowthView details →

Revenue YoY

+527.71%

EPS YoY

+83.64%

FCF YoY

+62.79%

Revenue CAGR 3Y

+124.11%

EPS CAGR 3Y

+143.55%

EBITDA YoY

+98.08%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

2.08x

Current Ratio

0.81x

Quick Ratio

0.56x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

898.12M

Net Income (TTM)

−71.72M

Op. CF (TTM)

76.68M

Next earningsMar 31, 2027 →

Latest newsMore news →

No recent news for 02181.HK.

Similar companies

Syndax Pharmaceuticals, Inc.SNDX Galapagos N.V.GLPG Taysha Gene Therapies, Inc.TSHA Mind Medicine (MindMed) Inc.MNMD 金迪克688670.SH Damora Therapeutics, Inc.DMRA Find similar companies →

Latest newsMore news →

No recent news for 02181.HK.